Discover how the cardiology experts our AI sourced for our customers helped to inform digital health strategies, pioneering new treatments and primary market research.
We’ve developed AI-powered search technology that scours billions of online data points to identify and connect your business with the most relevant experts in any field, faster than traditional expert networks. This speed and specificity enables us to support customers who work on projects in fast-moving and complex fields such as cardiology.
Learn more about some of the cardiology projects we've worked on and how the experts out AI recruited empowered our customers to make more informed decisions.
A healthcare strategy consultancy supporting their end client with a project on transthyretin amyloidosis (ATTR), a rare condition characterized by abnormal build-up of a protein called amyloid in the body's organs and tissues, needed to engage with subject matter experts to support their strategy.
The key opinion leaders (KOLs) needed to be:
With precision, speed and volume at its core, our AI search technology identified the KOLs the customer requested, enabling them to get the hands-on information they needed for their project.
The customer conducted qualitative interviews with KOLs including:
A business intelligence company needed an expert network to arrange qualitative interviews with cardiovascular (CVD) regulatory affairs KOLs to supplement their project.
The KOLs had to meet criteria such as:
Specificity is key when it comes to gaining insights from the right experts. We’ve built an internal Semantic Search Engine enabling us to accurately match experts to a request by inputting the relevant criteria the experts need to match. Such as, location, specialism, experience, and job title.
Using the Semantic Search Engine, we connected the customer with the exact experts they needed.
Our Semantic Search Engine ensures we connect our customers with experts who precisely match project requirements .
The CVD regulatory affairs KOLs the customer engaged with included:
Cardiologists and hematologist-oncologists deepen communications agency’s understanding of breakthrough leukemia treatment
Over the past decade, Bruton's tyrosine kinase inhibitors (BTKis) have increasingly replaced chemotherapy-based treatments in patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
A healthcare communications agency working on a BTKi project asked us to connect them with cardiologists within a US academic center or center of excellence experienced in treating cardiotoxic adverse events (AEs) in patients with CLL or MCL from treatment with BTKis.
Furthermore, the customer also wanted to engage with US-based hematologist-oncologists experienced in using BTKis to treat CLL.
With the requirements in hand, our AI went on the hunt to find the precision-matched experts for our customer, including:
Due to the impact of COVID-19, many organizations turned to online events to stay engaged with their audiences and target markets, including pharmaceutical companies.
A healthcare and life sciences consultancy working on a project for their end client needed to find out how COVID-19 has affected online events in medical education, and what can be changed to appeal to physicians.
As such, they needed to engage with various healthcare practitioners (HCPs) such as cardiologists, diabetologists, endocrinologists, obesity specialists and hepatologists across a range of countries including the UK, Brazil, Japan, Canada, Saudi Arabia, India, China, Germany, and France.
Unlike traditional expert networks, our AI isn’t confined to a static database of experts. Instead, it trawls through billions of publicly available online data points to identify the leading experts in any field. This allows us to connect our customers with experts from all over the world.
In 2020, we connected our customers with experts across more than 40 countries!
Some of the HCPs the customer engaged with were:
Drug-eluting balloons (DEB) and drug-eluting stents (DES) are tools used by cardiologists to widen blocked arteries to ensure good blood flow. Both these devices are coated in medication which is released into the vessel wall to facilitate the treatment.
According to recent reports, these two markets show no signs of slowing down. The DEB market is forecast to reach an estimated value of USD 1.8 Bn in 2026, growing at a CAGR of approximately 18% from 2018 - 2026 and the DES market is anticipated to reach USD 8.74 Bn by 2026, expanding at a CAGR of 5.67% from 2018 - 2026.
An investor relations consultancy was looking to connect with interventional cardiologists who work closely with these tools in adults as part of their primary market research. Based on the customer’s criteria, our technology identified first-class KOLs within a matter of hours and matched them with the customer, enabling them to get the insights they needed, swiftly.
Some of the experts our AI found for the customer included:
The healthcare technology landscape is evolving rapidly, and organizations are increasingly turning to technology to help improve health and wellness. A customer specializing in digital health needed to connect with experts to support them with several research projects, including one on cardiology.
They needed to engage with digital health specialists experienced in telemedicine, remote patient monitoring and remote patient diagnostics, virtual health assistance, and/or digital therapeutics with the aim of discovering the potential of digital health solutions in the field of cardiology.
The customer requested to connect with specialists from Europe, the US and Australia. Our AI successfully sourced the specialists they needed across the specified regions within just 48 hours, including:
Looking for cardiology experts or specialists in another field? Whatever you’re looking for, we’ve got you covered - contact us to find out how we can support your next project.